Limited value for ultrasonography in predicting flare in rheumatoid arthritis patients with low disease activity stopping TNF inhibitors

FB Lamers-Karnebeek, JJ Luime, DF Ten Cate… - …, 2017 - academic.oup.com
Objective Ultrasonography (US) can be used for treatment decisions in RA patients. This
study investigated the added value of US to clinical variables in predicting flare in RA patients …

Flare rate in patients with rheumatoid arthritis in low disease activity or remission when tapering or stopping synthetic or biologic DMARD: a systematic review

TM Kuijper, FBG Lamers-Karnebeek… - The Journal of …, 2015 - jrheum.org
Objective. To evaluate the risk of having a disease flare in patients with rheumatoid arthritis (RA)
with low disease activity (LDA) or in remission when deescalating (tapering or stopping) …

Adalimumab drug and antidrug antibody levels do not predict flare risk after stopping adalimumab in RA patients with low disease activity

FBG Lamers-Karnebeek, JWG Jacobs… - …, 2019 - academic.oup.com
Objective To establish whether serum adalimumab (ADA) trough level (ADA-TL) and antidrug
antibody (ADA-ab) level predict flare after stopping ADA in established RA patients with …

AB1253 Ultrasonographic signals have additive value for gout in patients presenting with mono-/oligoarthritis

FB Lamers-Karnebeek, AW van Lieshout… - Annals of the …, 2013 - ard.bmj.com
Background Mono-/oligoarthritis (MOA) may be evoked by intra-articular crystals or other (rheumatic)
disease. Crystal proof is an important diagnostic target for clinicians aiming at …

JN, Tchetverikov I, Vreugdenhil SA, van Woerkom JM, Goekoop-Ruiterman YPM, Landewé RBM, van Riel PLCM, van de Laar MAFJ, Jansen TL; Dutch National POET …

FB Lamers-Karnebeek, JJ Luime… - … Factor Inhibitors in …, 2019 - scholar.archive.org
Moghadam M, Efde MN, Goekoop-Ruiterman YPM, van Riel PLCM, Jacobs JWG, Jansen TL.
Limited value for ultrasonography in predicting flare in rheumatoid arthritis patients with …

Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial

FBG Lamers-Karnebeek, JJ Luime, TL Jansen… - …, 2020 - academic.oup.com
… Femke BG Lamers-Karnebeek , Femke BG Lamers-Karnebeek … Femke BG Lamers-Karnebeek,
Jolanda J Luime, Tim L Jansen, Piet LCM van Riel, Johannes WG Jacobs, Is …

Inhibition of IFNα secretion in cells from patients with juvenile dermatomyositis under TBK1 inhibitor treatment revealed by single-molecular assay technology

C Gitiaux, V Bondet, N Bekaddour, P Nusbaum… - …, 2020 - academic.oup.com
DEAR EDITOR, A type 1 IFN gene signature has been previously demonstrated in the
peripheral blood and muscle of patients with JDM, correlating with disease activity scores. …

This thesis

TM Kuijper - Patient Outcomes in the Treatment of Rheumatoid …, 2018 - core.ac.uk
Kuijper TM, Luime JJ, Xiong H, de Jong P, van der Lubbe P, van Zeben D, Tchetverikov I,
Hazes J, Weel A. Effects of psychosocial factors on monitoring treatment effect in newly …

POS1390 ULTRASOUND BASED WITHDRAWAL OF BIOLOGICS IN RHEUMATOID ARTHRITIS (RA-BioStop)

C Dejaco, I Gessl, R Husic, T Deimel, A Lackner… - 2022 - ard.bmj.com
Background Discontinuation of biological (b)DMARDs may be considered in rheumatoid
arthritis (RA) patients in persistent clinical remission [1]. Some earlier studies reported that …

Chasing the Ghost of Imaging Remission in Rheumatoid Arthritis

GS Kaeley, VK Ranganath - The Journal of Rheumatology, 2018 - jrheum.org
The role of musculoskeletal ultrasound (MSK-US) in rheumatoid arthritis (RA) is evolving,
albeit with twists and turns. Early RA randomized clinical studies have demonstrated little …